These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 369713)

  • 1. [Modification of serum lipid values and of the neurovegetative equilibrium in subjects under mazindol therapy].
    Zdichynec B; Rechmani BA
    Cesk Gastroenterol Vyz; 1979 Jan; 33(1):51-7. PubMed ID: 369713
    [No Abstract]   [Full Text] [Related]  

  • 2. A multi-centre general practice trial of mazindol in the treatment of obesity.
    Maclay WP; Wallace MG
    Practitioner; 1977 Mar; 218(1305):431-4. PubMed ID: 322112
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of mazindol in the treatment of essential obesity].
    Guazzelli R; Piazzini M; Conti C; Papi L; Strazzulla G; Matassi L
    Clin Ter; 1987 Mar; 120(5):385-91. PubMed ID: 2953538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the anorectic effect of mazindol and placebo in obesity].
    Tatoń J; Czech A; Koliński P; Podwysocka G
    Pol Tyg Lek; 1979 Dec; 34(50):1967-70. PubMed ID: 395517
    [No Abstract]   [Full Text] [Related]  

  • 5. A controlled trial of mazindol (Sanjorex, Teronac) in the management of the obese rheumatic patients.
    Thorpe PC; Isaac PF; Rodgers J
    Curr Ther Res Clin Exp; 1975 Feb; 17(2):149-55. PubMed ID: 803428
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mazindol in the treatment of obese diabetic patients].
    Dolecek R; Reil P; Skarpová O; Závada M
    Vnitr Lek; 1976 Aug; 22(8):798-804. PubMed ID: 788327
    [No Abstract]   [Full Text] [Related]  

  • 7. AN 448 Sandoz (Mazindol) in the treatment of obesity.
    Wallace AG
    Med J Aust; 1976 Mar; 1(11):343-5. PubMed ID: 775265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical trial with a nonamphetaminic anoretic].
    Campagnoli M
    Rev Iber Endocrinol; 1976; 23(137):463-83. PubMed ID: 794978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of Teronac (mazindol) in the treatment of obesity in children. Part II. Anorectic properties and side effects (author's transl)].
    Gołebiowska M; Chlebna-Sokół D; Kobierska I; Konopińska A; Małek M; Mastalska A; Zwaigzne-Raczyńska J
    Przegl Lek; 1981; 38(3):355-8. PubMed ID: 7017827
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of obesity with a non-amphetamine anorexigenic agent (author's transl)].
    Riesco J; Troncoso G; Costamaillere L; Rodríguez J
    Rev Med Chil; 1977 Jun; 105(6):375-9. PubMed ID: 331428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of simple obesity with mazindol under sanatorium conditions].
    Hasik J; Gawlak E; Tycowa M
    Pol Tyg Lek; 1980 Nov; 35(45):1729-31. PubMed ID: 7012806
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind clinical evaluation of mazindol (42-548) in obese diabetics.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):816-24. PubMed ID: 813947
    [No Abstract]   [Full Text] [Related]  

  • 13. Maziniol in the treatment of obesity.
    Sedgwick JP
    Practitioner; 1975 Mar; 214(1281):418-20. PubMed ID: 1096123
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of mazindol on some parameters of energy metabolism regulation in weight reduction of obese subjects (author's transl)].
    Rath R; Vondra K; Bass A; Kujalová V
    Bratisl Lek Listy; 1978 Feb; 69(2):170-9. PubMed ID: 343887
    [No Abstract]   [Full Text] [Related]  

  • 15. [Mazindol, an anorectic of a new series, in the treatment of obesity (author's transl)].
    Dolecek R
    Cas Lek Cesk; 1975 Feb; 114(8):249-54. PubMed ID: 1095197
    [No Abstract]   [Full Text] [Related]  

  • 16. [Teronac in the treatment of obesity].
    Zahorska-Markiewicz B
    Pol Tyg Lek; 1976 Jun; 31(25):1085-7. PubMed ID: 781638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative trial on the effects of diet, mazindol, and placebo in the treatment of exogenous obesity (author's transl)].
    Mies R
    Med Klin; 1976 Nov; 71(46):2013-6. PubMed ID: 995040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mazindol (Teronac) in the treatment of predominant by food-dependent obesity].
    Husmann F
    Med Welt; 1976 Oct; 27(40):1904-8. PubMed ID: 790077
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
    Defelice EA; Chaykin LB; Cohen A
    Curr Ther Res Clin Exp; 1973 Jul; 15(7):358-66. PubMed ID: 4198296
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity-mobilizing lipids and blood lipids in patients treated with Mazindol].
    Hasik J; Gryczka AZ; Paluszak J; Tycowa M
    Pol Arch Med Wewn; 1978 Nov; 60(5):401-4. PubMed ID: 724542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.